Scientists with the CDC who recently evaluated 22nd Century Group Inc. (NYSEMKT: XXII)’s SPECTRUM cigarettes have turned up with a positive verdict on the product. According to the researchers, SPECTRUM proved to be a critically important tool in investigating nicotine addiction in relation to cigarettes with reduced levels of nicotine.
The CDC scientists published their findings regarding 22nd Century Group Inc. (NYSEMKT: XXII)’s SPECTRUM cigarettes in the Tobacco Regulatory Science journal. The independent study, carried by a team of senior scientists with CDC, further highlights the commercial potential of SPECTRUM cigarettes in a world where risk of cancer is turning millions away from legacy tobacco cigarettes.
Impact of reducing nicotine in cigarette
Nicotine is the addictive chemical found in conventional tobacco products. The CDC scientists examining 22nd Century’s SPECTRUM cigarette sought to establish the impact that reduced nicotine content in a cigarette can have on tobacco addition. Such understanding is important in formulating the best policies in tobacco smoking regulation. Additionally, the knowledge of how tobacco addition is affected by varying the level of nicotine in the cigarette could help in achieving better results in smoking secession and reduction of harm resulting from tobacco smoking.
22nd Century Group Inc. (NYSEMKT: XXII)’s SPECTRUM doesn’t alter cigarette taste
The CDC researchers noted that there is a remarkable similarity in the physical and chemical properties of SPECTRUM when compared to conventional cigarettes, but with the added advantage that SPECTRUM contains exceptionally lower levels of nicotine. As such, users of SPECTRUM cigarettes cannot complain of loss of the typical taste of tobacco smoking. Instead, they can celebrate the benefit of lower nicotine content that makes it flexible for them to manage tobacco addition.
Reduced cancer risk
The CDC researchers also noted that 22nd Century Group Inc. (NYSEMKT: XXII)’s SPECTRUM cigarettes contain significantly reduced levels of two cancer-causing tobacco chemicals known as NNN and NNK compared to commercial cigarettes. For example, the scientists noted that the NNK content in SPECTRUM cigarettes is lower than the lowest levels that have been reported in traditional tobacco cigarettes. As for the concentration of NNN in SPECTRUM cigarettes, the researchers found it was at the lower-end of the concentration levels in legacy cigarettes.